Home
Benjamin L. Palleiko, CEO: KalVista Pharmaceuticals KALV Sell · Filed 24/08/21
Trade details
- Type
- Insider sale
- Amount
- $170,722.15
- Shares · price
- 14,215 sh · $12.01 a share
- Held after
- 242,527 sh
- Person
- Benjamin L. PalleikoCEO
- Trade date
- 24/08/19
- Filed
- 24/08/21
- Days to filing
- 2 days
Sold 5.5% of holdings
- Share of holding sold
- 5.5%
KalVista Pharmaceuticals trades, last 26 weeks
What else happened in KalVista Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 24/07/20~24/09/18Benjamin L. Palleiko's recent trades
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$292.6K
10,926 sh
$292.6K
Filed 05/26
Traded 05/22
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$30.2K
1,129 sh
$30.2K
Filed 05/19
Traded 05/18
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$88.7K
3,322 sh
$88.7K
Filed 05/13
Traded 05/12
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$193.1K
9,550 sh
$193.1K
Filed 04/20
Traded 04/17
- Benjamin L. Palleiko
SellKalVista Pharmaceuticals
SellKalVista Pharmaceuticals
KALV
$107.6K
6,693 sh
$107.6K
Filed 03/10
Traded 03/09